ArticleBeyoglu eye journal2024
Investigation of Refractive Errors in Congenital Nasolacrimal Duct Obstruction.
Article in Beyoglu eye journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Congenital Nasolacrimal Duct Obstruction: Natural Course, Diagnosis and Therapeutic Strategies.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Congenital nasolacrimal duct obstruction (CNLDO) is a condition that can lead to the development of anisometropia and amblyopia. This study aimed to identify refractive errors in children with unilateral and bilateral CNLDO. Methods: A total of 220 eyes from 110 patients with CNLDO were retrospectively analyzed in this study. All patients underwent at least one surgery, and their most recent refractive errors were compared based on the laterality of the disease. The risk factors for amblyopia were established in accordance with the 2013 and 2021 American Association for Pediatric Ophthalmology and Strabismus guidelines. The investigated risk factors included disease laterality, surgical technique, number of surgeries, age at the time of surgery, and manifest strabismus. Results: The nasolacrimal duct obstruction was unilateral in 66.4% (n=73) of the patients. The average ages at the last examination and at the time of surgery were 57.3±37.6 months (range: 12-153 months) and 29.6±22.3 months (range: 12-128 months), respectively. Hypermetropia was the most common refractive error, followed by astigmatism. The anisometropia and amblyopia rates were 11.8% (n=13) and 5.4% (n=6), respectively. No significant refractive difference was observed between the eyes in unilateral and bilateral CNLDO (p>0.05). After regression analyses, manifest strabismus was the only factor associated with amblyogenic risk factors in children with CNLDO (odds ratio = 0.132, 95% confidence interval = 0.529-17.400, p<0.001). Conclusion: As a result, children diagnosed with CNLDO should be treated at as optimal time as possible, and visual maturation should be monitored for the development of high hypermetropia, anisometropia, and amblyopia. These children should receive a complete ophthalmic examination, including cycloplegic refraction, and orthoptic evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.